Efficacy and safety of atorvastatin 10 mg every other day in hypercholesterolemia

Chumpol Piamsomboon1, Prasart Laothavorn, Sopon Saguanwong

  • 1Department of Medicine, Phramongkutklao College of Medicine, Bangkok, Thailand.

Insights

Atorvastatin 10 mg every other day effectively lowers high cholesterol, including total cholesterol, triglycerides, and LDL-c, in hypercholesterolemia patients. This dosing regimen demonstrates good safety and may be a cost-effective option.

Area of Science:

  • Cardiology
  • Pharmacology
  • Metabolic Disorders

Background:

  • Statins effectively reduce cardiovascular events but are costly.
  • Atorvastatin, a potent statin with a long half-life, presents a potential for alternative dosing strategies.
  • Exploring cost-effective hypercholesterolemia management is crucial.

Purpose of the Study:

  • To assess the safety and efficacy of administering atorvastatin every other day.
  • To evaluate the impact of alternate-day atorvastatin on lipid profiles in hypercholesterolemia patients.

Main Methods:

  • Sixty hypercholesterolemia patients received atorvastatin 10 mg every other day for 8 weeks.
  • Lipid profiles (TC, TG, LDL-c, HDL-c) were measured at baseline, 4 weeks, and 8 weeks.
  • Adverse events were monitored throughout the study period.

Main Results:

  • Significant reductions observed in total cholesterol (23%), triglycerides (8%), and LDL-c (30%) compared to baseline.
  • No statistically significant increase in HDL-c levels was noted.
  • Three patients experienced mild side effects: elevated transaminase, elevated muscle enzyme, and somnolence.

Conclusions:

  • Alternate-day atorvastatin (10 mg) is a safe and effective strategy for managing hypercholesterolemia.
  • This regimen successfully lowers key lipid parameters (TC, TG, LDL-c) with a minor increase in HDL-c.
  • The findings suggest potential for cost-effective lipid management in hypercholesterolemia.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...